Alnylam Pharmaceuticals reported $52.42M in Trade Creditors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 11.85M 1.09M
Agios Pharmaceuticals AGIO:US $ 7.79M 3.76M
Alnylam Pharmaceuticals ALNY:US $ 52.42M 2.5M
Amgen AMGN:US $ 1256M 147M
Arrowhead Research ARWR:US $ 5.89M 4.71M
Avrobio Inc AVRO:US 28K 4.01M
Bluebird Bio BLUE:US $ 24.86M 3.48M
Intercept Pharmaceuticals ICPT:US $ 11.67M 1.28M
IONIS PHARMACEUT IONS:US $ 10.35M 5.77M
Mirati Therapeutics MRTX:US $ 24.27M 3.67M
Moderna Inc MRNA:US 181M 18M
Novartis NVS:US $ 4969M 114M
Ptc Therapeutics PTCT:US $ 22.88M 4.52M
Regeneron Pharmaceuticals REGN:US $ 534.2M 63.9M
Regulus Therapeutics RGLS:US $ 0.6M 0.03M
Sangamo Biosciences SGMO:US 13.08M 1.93M
Sarepta Therapeutics SRPT:US $ 56.21M 2.2M
Takeda 4502:JP Y 424358M 91939M
Ultragenyx Pharmaceutical RARE:US $ 34.21M 10.53M
Vertex Pharmaceuticals VRTX:US $ 198M 24.4M
Xencor XNCR:US $ 15.75M 3.84M
YTE INCY:US $ 194.77M 42.22M